These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 30211436

  • 1. Adherence in patients with atrial fibrillation treated with dabigatran.
    Grześk G, Janiszewska E, Malinowski B, Kubica A, Wiciński M.
    Kardiol Pol; 2018; 76(11):1562-1563. PubMed ID: 30211436
    [No Abstract] [Full Text] [Related]

  • 2. Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation.
    Del-Carpio Munoz F, Yao X, Abraham NS, Bellolio MF, Rabinstein AA, Asirvatham SJ, McBane RD, Gersh BJ, Shah ND, Noseworthy PA.
    J Am Coll Cardiol; 2016 Jul 05; 68(1):129-31. PubMed ID: 27364057
    [No Abstract] [Full Text] [Related]

  • 3. Two-year follow-up of patients treated with dabigatran for stroke prevention in atrial fibrillation: Global Registry on Long-Term Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) registry.
    Huisman MV, Rothman KJ, Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Zint K, Elsaesser A, Lu S, Bartels DB, Lip GYH, GLORIA-AF Investigators.
    Am Heart J; 2018 Apr 05; 198():55-63. PubMed ID: 29653649
    [Abstract] [Full Text] [Related]

  • 4. Sex Differences in Dabigatran Use, Safety, And Effectiveness In a Population-Based Cohort of Patients With Atrial Fibrillation.
    Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Pilote L.
    Circ Cardiovasc Qual Outcomes; 2015 Nov 05; 8(6):593-9. PubMed ID: 26508666
    [Abstract] [Full Text] [Related]

  • 5. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
    Zalesak M, Siu K, Francis K, Yu C, Alvrtsyan H, Rao Y, Walker D, Sander S, Miyasato G, Matchar D, Sanchez H.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):567-74. PubMed ID: 23922182
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study.
    Verdecchia P, Vedovati MC, Conti S, Giustozzi M, Aita A, Molini G, Angeli F, Turturiello D, Becattini C, Cavallini C, Agnelli G.
    Expert Opin Drug Saf; 2018 Nov 01; 17(11):1063-1069. PubMed ID: 30260252
    [Abstract] [Full Text] [Related]

  • 7. Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.
    Romanelli RJ, Nolting L, Dolginsky M, Kym E, Orrico KB.
    Circ Cardiovasc Qual Outcomes; 2016 Mar 01; 9(2):126-34. PubMed ID: 26812933
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of indications for reduced-dose non-vitamin K antagonist oral anticoagulants in hospitalised patients with atrial fibrillation.
    Jelonek O, Gorczyca I, Bączek M, Kośmider P, Wożakowska-Kapłon B.
    Kardiol Pol; 2018 Mar 01; 76(7):1073-1080. PubMed ID: 29441513
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Characteristics and Outcomes of Dabigatran Versus Warfarin in Hypertensive Patients With Atrial Fibrillation (from the RE-LY Trial).
    Nagarakanti R, Wallentin L, Noack H, Brueckmann M, Reilly P, Clemens A, Connolly SJ, Yusuf S, Ezekowitz MD.
    Am J Cardiol; 2015 Oct 15; 116(8):1204-9. PubMed ID: 26282726
    [Abstract] [Full Text] [Related]

  • 10. Strategies for improving dabigatran adherence for stroke prevention in patients with non-valvular atrial fibrillation: education and drug intake reminders (FACILITA study).
    Márquez-Contreras E, Martell-Claros N, Márquez-Rivero S, Hermida-Campa E, Gracia-Diez C, Sanchez-López E, Gil-Guillén V, Compliance and Inertia Working Group, Spanish Society of Hypertension (SEH-LELHA).
    Curr Med Res Opin; 2018 Jul 15; 34(7):1301-1308. PubMed ID: 29384410
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients.
    Lai CL, Chen HM, Liao MT, Lin TT, Chan KA.
    J Am Heart Assoc; 2017 Apr 24; 6(4):. PubMed ID: 28438735
    [Abstract] [Full Text] [Related]

  • 12. Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
    Lee CH, Lin TY, Chang SH, Chen CH, Hsu YJ, Hung KC, Wen MS.
    Int J Cardiol; 2017 Feb 01; 228():771-778. PubMed ID: 27888754
    [Abstract] [Full Text] [Related]

  • 13. [New oral anticoagulants in patients with atrial fibrillation in a urban health center].
    Rodríguez Pérez L, Capilla Lozano F, Gallego Fuentes R, Buitrago F.
    Med Clin (Barc); 2016 Mar 18; 146(6):280-1. PubMed ID: 26343157
    [No Abstract] [Full Text] [Related]

  • 14. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
    Larsen TB, Rasmussen LH, Gorst-Rasmussen A, Skjøth F, Lane DA, Lip GY.
    Am J Med; 2014 Dec 18; 127(12):1172-8.e5. PubMed ID: 25193361
    [Abstract] [Full Text] [Related]

  • 15. Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.
    Bundhun PK, Soogund MZ, Teeluck AR, Pursun M, Bhurtu A, Huang WQ.
    BMC Cardiovasc Disord; 2017 Jan 06; 17(1):15. PubMed ID: 28056795
    [Abstract] [Full Text] [Related]

  • 16. Comparison of different oral anticoagulant regimens in patients with atrial fibrillation undergoing ablation or cardioversion.
    Gawałko M, Kapłon-Cieślicka A, Budnik M, Babiarz A, Bodys A, Uliński R, Żochowski M, Peller M, Scisło P, Kochanowski J, Filipiak KJ, Opolski G.
    Pol Arch Intern Med; 2017 Dec 22; 127(12):823-831. PubMed ID: 28972957
    [Abstract] [Full Text] [Related]

  • 17. [Not Available].
    Oldgren J.
    Lakartidningen; 2018 Dec 04; 115():. PubMed ID: 30512140
    [No Abstract] [Full Text] [Related]

  • 18. Factors associated with abrupt discontinuation of dabigatran therapy in patients with atrial fibrillation in Malaysia.
    Beshir SA, Chee KH, Lo YL.
    Int J Clin Pharm; 2016 Oct 04; 38(5):1182-90. PubMed ID: 27450507
    [Abstract] [Full Text] [Related]

  • 19. New oral anticoagulants for patients with nonvalvular atrial fibrillation.
    Holden A, Azimi N, Forest CP.
    JAAPA; 2015 Nov 04; 28(11):28-34. PubMed ID: 26501575
    [Abstract] [Full Text] [Related]

  • 20. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
    Noseworthy PA, Yao X, Abraham NS, Sangaralingham LR, McBane RD, Shah ND.
    Chest; 2016 Dec 04; 150(6):1302-1312. PubMed ID: 27938741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.